LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.

MLA

Haase, Christiane L., et al. “LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals.” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, Feb. 2012, pp. E248–56. EBSCOhost, https://doi.org/10.1210/jc.2011-1846.

APA

Haase, C. L., Tybjærg-Hansen, A., Qayyum, A. A., Schou, J., Nordestgaard, B. G., & Frikke-Schmidt, R. (2012). LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. The Journal of Clinical Endocrinology and Metabolism, 97(2), E248–E256. https://doi.org/10.1210/jc.2011-1846

Chicago

Haase, Christiane L, Anne Tybjærg-Hansen, Abbas Ali Qayyum, Jesper Schou, Børge G Nordestgaard, and Ruth Frikke-Schmidt. 2012. “LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals.” The Journal of Clinical Endocrinology and Metabolism 97 (2): E248–56. doi:10.1210/jc.2011-1846.